How Frequently Should Patients with Breast Cancer Have Routine Follow-Up Visits?

Beltran-Bless, Ana-Alicia; Clemons, Mark

doi:10.1056/evidtt2300062

Cited by 1 publication

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The frequency and nature of breast cancer follow-up after patients complete the acute phase of their treatment vary between and within different institutions [ 24 ]. Guideline recommendations are not supported by any level I evidence.…”

Section: Review Of Recently Completed and Currently Accruing React St...mentioning

confidence: 99%

The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care

Beltran-Bless,

Clemons,

Vandermeer

et al. 2024

Current Oncology

Self Cite

View full text Add to dashboard Cite

Patients, families, healthcare providers and funders face multiple comparable treatment options without knowing which provides the best quality of care. As a step towards improving this, the REthinking Clinical Trials (REaCT) pragmatic trials program started in 2014 to break down many of the traditional barriers to performing clinical trials. However, until other innovative methodologies become widely used, the impact of this program will remain limited. These innovations include the incorporation of near equivalence analyses and the incorporation of artificial intelligence (AI) into clinical trial design. Near equivalence analyses allow for the comparison of different treatments (drug and non-drug) using quality of life, toxicity, cost-effectiveness, and pharmacokinetic/pharmacodynamic data. AI offers unique opportunities to maximize the information gleaned from clinical trials, reduces sample size estimates, and can potentially “rescue” poorly accruing trials. On 2 May 2023, the first REaCT international symposium took place to connect clinicians and scientists, set goals and identify future avenues for investigator-led clinical trials. Here, we summarize the topics presented at this meeting to promote sharing and support other similarly motivated groups to learn and share their experiences.

show abstract

Section: Review Of Recently Completed and Currently Accruing React St...mentioning

confidence: 99%

The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care

Beltran-Bless,

Clemons,

Vandermeer

et al. 2024

Current Oncology

Self Cite

View full text Add to dashboard Cite

show abstract

How Frequently Should Patients with Breast Cancer Have Routine Follow-Up Visits?

Cited by 1 publication

References 12 publications

The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care

The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care

Contact Info

Product

Resources

About